Pathologic Complete Response to Preoperative Chemotherapy Predicts Cure in Early- Stage Non–Small-Cell Lung Cancer: Combined Analysis of Two IFCT Randomized Trials Guillaume Mouillet, Msc, Elisabeth Monnet, MD, Bernard Milleron, MD, Marc Puyraveau, MSc, Elisabeth Quoix, MD, Philippe David, MD, Alain Ducoloné, MD, Olivier Molinier, MD, Gérard Zalcman, MD, PhD, Alain Depierre, MD, Virginie Westeel, MD, PhD Journal of Thoracic Oncology Volume 7, Issue 5, Pages 841-849 (May 2012) DOI: 10.1097/JTO.0b013e31824c7d92 Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions
FIGURE 1 Trial I design. Journal of Thoracic Oncology 2012 7, 841-849DOI: (10.1097/JTO.0b013e31824c7d92) Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions
FIGURE 2 Trial II design. Journal of Thoracic Oncology 2012 7, 841-849DOI: (10.1097/JTO.0b013e31824c7d92) Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions
FIGURE 3 Flow chart. Journal of Thoracic Oncology 2012 7, 841-849DOI: (10.1097/JTO.0b013e31824c7d92) Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions
FIGURE 4 Kaplan–Meier survival plots according to pathologic response: (A) Overall survival (B) Disease-free survival. *Log-rank test. Journal of Thoracic Oncology 2012 7, 841-849DOI: (10.1097/JTO.0b013e31824c7d92) Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions